Psilocybin Magic Mushrooms Uses, Effects & Hazards
Inhaltsverzeichnis
The Effects, Risks, and Potential Health Benefits of “Magic Mushrooms”Extent of Hallucinogenic Mushroom Use
Yet, even with careful screening, psilocybin is not perfect. In the COMPASS Pathways study, 77% of participants had headache, nausea, fatigue and dizziness, regardless of psilocybin dosage. A few participants reported suicidal ideation and self-injurious behavior which, though “common in treatment-resistant depression studies,” according to the company, must be considered as research progresses.
Abuse of psilocybin mushrooms could also lead to toxicity or death if a poisonous mushroom is incorrectly thought to be a "magic" mushroom and ingested.On the one hand, it could provide funding for research; on the other, the desire for a return on that investment could improperly influence the results and put patients at risk.The concentration of active psilocybin mushroom compounds varies from species to species but also from mushroom to mushroom within a given species, subspecies or variety.[42] The species Psilocybe azurescens contains the most psilocybin (up to 1.78%).Other tryptamine compounds such as serotonin is also commonly found in Gymnopilus species, suggesting that the genus has species with possible undiscovered tryptamines.
That decision was followed this May with Denver’s vote to in effect decriminalise magic mushrooms, making it the first US city to do so, followed last week by a similar measure for several psychedelic plants in Oakland, California. Activists are pushing for a state-wide vote in Oregon next year on whether to legalise psilocybin for medical use. Meanwhile, Compass hopes to request marketing authorisation for the drug within three years, if its trials are successful. It is proceeding slowly, though, having treated around six people since trials began in January, and Malievskaia says the process could take a decade until approval. She aims to accelerate progress, with new treatment sites recently opened at Columbia University, as well as in New Orleans and the Netherlands, among others.
Dried mushrooms are a rusty brown color with isolated areas of off-white. Although certain cultures have been known to use the hallucinogenic properties of some mushrooms for centuries, psilocybin was first isolated in 1958 by Dr. Albert Hofmann, who also discovered lysergic acid diethylamide (LSD). Psilocybin is considered one of the most well-known psychedelics, according to the Substance Abuse and Mental Health Services Administration (SAMHSA). Psilocybin is classified as a Schedule I drug, meaning that it has a high potential for misuse and has no currently accepted medical use in treatment in the United States. Common hallucinogens, with the possible exception of phencyclidine (PCP), are not usually tested for on standard workplace drug screens. However, if desired by legal authorities, medical personnel, or an employer, it is possible to perform laboratory assays that can detect any drug or metabolite, including psilocybin, via advanced laboratory techniques.
The Effects, Risks, and Potential Health Benefits of “Magic Mushrooms”
Gymnopilus spectabilis, a known psychedelic mushroom, looks alike to Armillaria mellea, an edible mushroom (Spring et al., 2016) and accidental ingestions of G. Galerina is also morphology similar to Gymnopilus and a possible synonymous genus (Landry, 2016; Kalichman et al., 2020). Species of Armillaria, Galerina, and Gymnopilus (such as Gymnopilus junonius, and Gymnopilus spectabilis) (Figure 1L) have been reported as poisonous (Maeta et al., 2008; Konno, 2009; Chen et al., 2014; Lee et al., 2020). Many widely distributed species of Pluteus have available DNA sequence data (Rodriguez et al., 2008; Justo et al., 2014; Araujo and Sampaio-Maia, 2018; Hosen et al., 2019; Ševčíková et al., 2021). Eight species were sequenced for ITS data including Plu. Paucicystidiatus (Menolli et al., 2015) and a further 12 species were sequenced for the ITS and tef1 gene regions (Justo et al., 2014).
Extent of Hallucinogenic Mushroom Use
Treatment and rehabilitation can be effective, but it requires commitment and effort from the individual to make positive life changes. To learn more about treatment options for Psilocybin Mushroom addiction, contact a treatment provider today for free. Treatment programs can provide a structured and secure environment for people http://www.bausch.co.jp/ja-jp/redirect/?url=https://acsauhaya.org/reservation/ to focus on their recovery and develop the necessary skills to maintain long-term sobriety. However, whether a person needs inpatient or outpatient treatment depends on their specific needs, level of substance abuse, and various other factors. Psilocybin mushroom abuse is a growing concern, particularly among younger populations.
Answering these questions will require completion of more clinical trials with a greater number of participants. Despite being used by people in Central America (and possibly other regions) for centuries, psychedelic mushrooms largely existed outside of Western societies until the 1950s, when an American mycologist, R. Gordon Wasson, took a trip to Huautla de Jiménez in Oaxaca, Mexico. There, he participated in a ritual using psychedelic mushrooms—the experience was captured in a 1957 article in Life magazine titled “Seeking the Magic Mushroom,” which introduced the fungi to a broad audience. A growing body of research suggests that, when administered in controlled conditions with supportive therapy, the compound may be useful for treating various psychiatric disorders, like depression.
